Pfizer receives FDA approval to test adolescents in Covid-19 vaccine trial

To date, all the major clinical trials of vaccines against COVID-19 have been in adults. Pfizer have received approval to enrol children as young as 12 years of age in its COVID-19 vaccine trial to determine its safety and efficacy in this age group.

Source:

Biospace Inc.